Stocks
Intercept Pharmaceuticals (ICPT) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 124 132% | 21 373% | 4 921% | 46 668% | 31 098% | 39 513% | |||
| Changes by years, y/y, % | +122 290pp | -102 759pp | -16 452pp | +41 747pp | -15 570pp | +76.0% | |||
Intercept Pharmaceuticals. R&D/CAPEX, %
Intercept Pharmaceuticals. R&D/CAPEX, changes, pp
Intercept Pharmaceuticals (ICPT) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | 2023Q3 | LTM ? | |||
| R&D/CAPEX, % | 13 184% | 13 697% | 38 067% | 319 331% | 39 513% | |||
| Changes by years, y/y, % | -686 986pp | +29 513pp | +306 147pp | |||||
| Changes by quarters, q/q, % | +4 629pp | +513pp | -13 697pp | +281 263pp | ||||
